RECRO PHARMA INC (REPH) Stock Analyst Ratings
NASDAQ:REPH - Nasdaq - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to REPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 144.02% above the current price.
REPH was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about REPH.
In the previous month the buy percentage consensus was at a similar level.
REPH was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-10-12 | William Blair | Initiate | Outperform |